Skip to main content

Disorders of Fructose Metabolism

  • Chapter
Inborn Metabolic Diseases

Abstract

Three inborn errors are known in the pathway of fructose metabolism depicted in ◘ Fig. 9.1. Essential fructosuria is a harmless anomaly characterised by the appearance of fructose in the urine after the intake of fructose-containing food. In hereditary fructose intolerance (HFI), fructose may provoke prompt gastrointestinal discomfort and hypoglycaemia upon ingestion, symptoms that may vary from patient to patient and depend on the ingested dose. Fructose may cause liver and kidney failure when taken persistently, and its intake becomes life threatening when it is given intravenously. Fructose-1,6-bisphosphatase (FBPase) deficiency is also usually considered an inborn error of fructose metabolism although, strictly speaking, it is a defect of gluconeogenesis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 159.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Cox TM (2002) The genetic consequences of our sweet tooth. Nat Rev Genet 3:481–487

    PubMed  CAS  Google Scholar 

  2. Asipu A, Hayward BE, O‘Reilly J, Bonthron DT (2003) Properties of normal and mutant recombinant human ketohexokinases and implications for the pathogenesis of essential fructosuria. Diabetes 52:2426–2432

    Article  PubMed  CAS  Google Scholar 

  3. Bonthron DT, Brady N, Donaldson IA, Steinmann B (1994) Molecular basis of essential fructosuria: molecular cloning and mutational analysis of human ketohexokinase (fructokinase). Hum Mol Genet 3:1627–1631

    Article  PubMed  CAS  Google Scholar 

  4. Trinh CH, Asipu A, Bonthron DT, Phillips SE (2009) Structures of alternatively spliced isoforms of human ketohexokinase. Acta Crystallogr D Biol Crystallogr 65:201–211

    Article  PubMed  Google Scholar 

  5. Boesiger P, Buchli R, Meier D, Steinmann B, Gitzelmann R (1994) Changes of liver metabolite concentrations in adults with disorders of fructose metabolism after intravenous fructose by 31P magnetic resonance spectroscopy. Pediatr Res 36:436–440

    Article  PubMed  CAS  Google Scholar 

  6. Froesch ER, Prader A, Labhart A, Stuber HW, Wolf HP (1957) Die hereditäre Fructoseintoleranz, eine bisher nicht bekannte kongenitale Stoffwechselstörung. Schweiz Med Wochenschr 87:1168–1171

    PubMed  CAS  Google Scholar 

  7. Baerlocher K, Gitzelmann R, Steinmann B, Gitzelmann-Cumarasamy N (1978) Hereditary fructose intolerance in early childhood: a major diagnostic challenge. Survey of 20 symptomatic cases. Helv Paediatr Acta 33:465–487

    PubMed  CAS  Google Scholar 

  8. Mock DM, Perman JA, Thaler MM, Morris RC Jr (1983) Chronic fructose intoxication after infancy in children with hereditary fructose intolerance. A cause of growth retardation. N Engl J Med 309:764–770

    Article  PubMed  CAS  Google Scholar 

  9. Lameire N, Mussche M, Baele G, Kint J, Ringoir S (1978) Hereditary fructose intolerance: a difficult diagnosis in the adult. Am J Med 65:416–423

    Article  PubMed  CAS  Google Scholar 

  10. Berghe v d G (1978) Metabolic effects of fructose in the liver. Curr Top Cell Regul 13:97–135

    Google Scholar 

  11. Jaeken J, Pirard M, Adamowicz M, Pronicka E, Van Schaftingen E (1996) Inhibition of phosphomannose isomerase by fructose-1-phosphate: an explanation for defective N-glycosylation in hereditary fructose intolerance. Pediatr Res 40:764–766

    Article  PubMed  CAS  Google Scholar 

  12. Woods HF, Alberti KGMM (1972) Dangers of intravenous fructose. Lancet II:1354–1357

    Article  Google Scholar 

  13. Cross NCP, de Franchis R, Sebastio G et al. (1990) Molecular analysis of aldolase B genes in hereditary fructose intolerance. Lancet I:306–309

    Article  Google Scholar 

  14. Coffee EM, Tolan DR (2010) Mutations in the promoter region of the aldolase B gene that cause hereditary fructose intolerance. J Inherit Metab Dis 33:715–725

    Article  PubMed  CAS  Google Scholar 

  15. Bouteldja N, Timson DJ (2010) The biochemical basis of hereditary fructose intolerance. J Inher Metab Dis 33: 105–112

    Article  PubMed  CAS  Google Scholar 

  16. Santer R, Rischewski J, Weihe v M et al. (2005) The spectrum of aldolase B (ALDOB) mutations and the prevalence of hereditary fructose intolerance in Central Europe. Hum Mutat 25:594

    Article  PubMed  Google Scholar 

  17. Kullberg-Lindh C, Hannoun C, Lindh M (2002) Simple method for detection of mutations causing hereditary fructose intolerance. J Inherit Metab Dis 25:571–575

    Article  PubMed  CAS  Google Scholar 

  18. Steinmann B, Gitzelmann R (1981) The diagnosis of hereditary fructose intolerance. Helv Paediatr Acta 36:297–316

    PubMed  CAS  Google Scholar 

  19. Gibson PR, Newnham E, Barrett JS, Shepherd SJ, Muir JG (2007) Fructose malabsorption and the bigger picture. Aliment Pharmacol Ther 25:349–363

    Article  PubMed  CAS  Google Scholar 

  20. Müller P, Meier C, Böhme HJ, Richter T (2003) Fructose breath hydrogen test – is it really a harmless diagnostic procedure? Dig Dis 21:276–278

    Article  PubMed  Google Scholar 

  21. European Union (1991) Commission Directive of 14 May 1991 on infant formulae and follow-on formulae (91/321/EEC) (1991) No L 175/35–51

    Google Scholar 

  22. Odièvre M, Gentil C, Gautier M, Alagille D (1978) Hereditary fructose intolerance in childhood. Diagnosis, management and course in 55 patients. Am J Dis Child 132:605–608

    PubMed  Google Scholar 

  23. Baker L, Winegrad AI (1970) Fasting hypoglycemia and metabolic acidosis associated with deficiency of hepatic fructose-1,6-bisphosphatase activity. Lancet 2:13–16

    Article  PubMed  CAS  Google Scholar 

  24. Visser G, Bakker HD, de Klerk JBC et al. (2004) Natural history and treatment of fructose 1,6-diphosphatase deficiency in the Netherlands (abstract). J Inherit Metab Dis 27 [Suppl 1]:207

    Google Scholar 

  25. Krishnamurthy V, Eschrich K, Boney A et al. (2007) Three successful pregnancies through dietary management of fructose-1,6-bisphosphatase deficiency. J Inherit Metab Dis 30:819

    Article  PubMed  CAS  Google Scholar 

  26. Åsberg C, Hjalmarson O, Alm J et al. (2010) Fructose 1,6-bisphosphatase deficiency: enzyme and mutation analysis performed on calcitriol-stimulated monocytes with a note on long-term prognosis. J Inherit Metab Dis 33:178

    Google Scholar 

  27. Morris AA, Deshphande S, Ward-Platt MP et al. (1995) Impaired ketogenesis in fructose-1,6-bisphosphatase deficiency: a pitfall in the investigation of hypoglycemia. J Inherit Metab Dis 18:28–32

    Article  PubMed  CAS  Google Scholar 

  28. Huidekoper HH, Visser G, Ackermans MT, Sauerwein HP, Wijburg FA (2010) A potential role for muscle in glucose homeostasis: in vivo kinetic studies in glycogen storage disease type 1a and fructose-1,6-bisphosphatase deficiency. J Inherit Metab Dis 33:25–31

    Article  PubMed  CAS  Google Scholar 

  29. El-Maghrabi MR, Lange AJ, Jiang W et al. (1995) Human fructose-1,6-bisphos phatase gene (FBP1): exon-intron organization, localization to chromosome bands 9q22.2-q22.3, and mutation screening in subjects with fructose-1,6-bisphos phatase deficiency. Genomics 27:520–525

    Article  PubMed  CAS  Google Scholar 

  30. Kikawa Y, Inuzuka M, Jin BY et al. (1997) Identification of genetic mutations in Japanese patients with fructose-1,6-bisphosphatase deficiency. Am J Hum Genet 61:852–861

    Article  PubMed  CAS  Google Scholar 

  31. Herzog B, Morris AA, Saunders C, Eschrich K (2001) Mutation spectrum in patients with fructose-1,6-bisphosphatase deficiency. J Inherit Metab Dis. 24:87–88

    Article  PubMed  CAS  Google Scholar 

  32. Hers HG, Schaftingen v E (1982) Fructose 2,6-bisphosphate two years after its discovery. Biochem J 206:1–12

    PubMed  CAS  Google Scholar 

  33. Besley GTN, Walter JH, Lewis MA, Chard CR, Addison GM (1994) Fructose-1,6-bisphosphatase deficiency: severe phenotype with normal leukocyte enzyme activity. J Inherit Metab Dis 17:333–335

    Article  PubMed  CAS  Google Scholar 

  34. Hasegawa Y, Kikawa Y, Miyamaoto J et al. (2003) Intravenous glycerol therapy should not be used in patients with unrecognized fructose-1,6-bisphosphatase deficiency. Pediatr Int 45:5–9

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Steinmann, B., Santer, R. (2012). Disorders of Fructose Metabolism. In: Saudubray, JM., van den Berghe, G., Walter, J.H. (eds) Inborn Metabolic Diseases. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-15720-2_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-15720-2_9

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-15719-6

  • Online ISBN: 978-3-642-15720-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics